SEC Form 4 · accession 0000899243-17-012901
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis D Kim
Officer — Chief Medical Officer
Period of report
May 10, 2017
Accepted (ET)
May 11, 2017 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 10, 2017 | P | 200 | $4.40 | A | 1,643 | D | |
| Common StockF1 | May 11, 2017 | P | 9,800 | $4.40 | A | 11,443 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 646 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on January 1, 2015, 699 shares acquired under the Plan on July 1, 2015 and 98 shares acquired under the Plan on January 1, 2016.